reconstitution for retatrutide Beginner's Guide: Reconstitution, Dosing & Getting Started | PeptIQ Blog Retatrutide Reconstitution Calculator | Simple

Retatrutide is given using a pen injector (1)

doi: 10.3389/fnut.2024.1398059

Indeed, a 2022 study found that after stopping a regimen of Semaglutide, the active ingredient in Ozempic, patients regained 2/3rds of the weight loss within one year

However, a newer oral agent in development called Orforglipron has shown much better bioavailability and produced around 1415% weight loss in Phase 2 trials, making it nearly comparable to current injectables

Accessing Retatrutide in Canada Retatrutide remains in clinical trials and lacks Health Canada approval as of 2025

Its triple receptor activation mechanism achieves bidirectional regulation of blood glucose by enhancing insulin secretion (GLP-1/GIP receptors) and inhibiting glucagon release (GLP-1 receptor)